On viewFilm & Screen

Oscar-Tipped Elizabeth Holmes Documentary Asks Why We Can't Look Away

A new Oscar-tipped documentary on Elizabeth Holmes opens with oncologist David Agus's account of meeting two different women: one in the green room, another on stage.

‘You can’t make this stuff up’: why we remain fascinated by Elizabeth Holmes
‘You can’t make this stuff up’: why we remain fascinated by Elizabeth Holmes12019 / pixabay

Programme

  1. Elizabeth Holmes is the subject of a new Oscar-tipped documentary examining her legacy
  2. Oncologist David Agus describes Holmes's accent and demeanor changing between green room and stage
  3. Agus: "It was as if I had met a person and then interviewed a separate person"
  4. The film takes an unusual angle on why public fascination with Holmes persists

By Tom Whitfield

Elizabeth Holmes, the entrepreneur convicted of fraud, is the subject of a new Oscar-tipped documentary that takes an unusual look at her strange legacy — and one of its witnesses still cannot reconcile the two women he met in a single afternoon.

David Agus, a medical oncologist, first encountered Holmes at a health conference. What happened in the green room startled him. Off stage, Holmes was personable and pleasant. On stage, she became someone else.

"The accent changed: this deep voice, very serious," Agus recalls by phone from Los Angeles. "It was as if I had met a person and then interviewed a separate person. That transition from the green room to the stage – I had never experienced something like that before."

The film's framing, according to its promoters, is captured in its own tagline: "You can't make this stuff up." The documentary positions Holmes's story as one that outruns fiction — the reason, its makers suggest, we remain fascinated by her.

What does the film actually add?

That is the practical question, and on the evidence available so far the answer is: testimony. Agus's account is the kind of first-hand detail the genre runs on — a named witness describing a documented, repeated behavior rather than a psychologist speculating about one.

What the promotional material does not say is equally telling. There is no claim yet of a new interview with Holmes herself, no new forensic finding, no footage described that would alter the factual record. "Oscar-tipped" is a distributor's word, not a voter's; it promises buzz, not a nomination.

The unusual look the film promises at her "strange legacy" remains undefined in the material released. Legacy implies aftermath — what Holmes means now, years after the collapse of Theranos and her conviction. Whether the documentary delivers that reckoning, or reassembles familiar material around fresh witnesses like Agus, viewers will have to judge for themselves.

Agus's green-room story, at least, has the virtue of specificity. A voice that drops. A demeanor that hardens. A physician who has interviewed many public figures saying he had never seen anything like it.

The fascination the film interrogates is not hard to test. Holmes generated series, books, podcasts and dramatizations before this documentary. Each retelling has found an audience. This one bets that a documentary treatment — with witnesses speaking on the record — can still add something the scripted versions could not.

Whether the Academy agrees, and whether Agus's two-Holmes account becomes the film's defining clip, will become clear as the documentary reaches audiences and the awards season unfolds.

Original: davidagus.com

elizabeth-holmes, theranos, documentary, oscar, fraud

Also on view

« Previous articleNext article »